Belite Bio, Inc

BLTENASDAQHealthcareBiotechnology

$143.35- (-)1Y +62.95%

As of Oct 26, 2026 close

Market cap: $5.76B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $88.00$200.00
Volume (live): -
Avg. volume (3M): 146.55K

Belite Bio, Inc (BLTE) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Belite Bio, Inc stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(12 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$236.86

+65.23% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest BLTE Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 15, 2026	Yi Chen	HC Wainwright	Reiterates	Buy	$245.00
Sep 9, 2026	Graig Suvannavejh	Mizuho	Maintains	Buy	$220.00 → $234.00 +14.00 (+6.4%)
Sep 9, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 8, 2026	Yi Chen	HC Wainwright	Reiterates	Buy	$214.00 → $245.00 +31.00 (+14.5%)
Sep 4, 2026	Whitney Ijem	Canaccord Genuity	Initiates	Buy	$303.00
Sep 3, 2026	Tazeen Ahmad	BofA Securities	Maintains	Buy	$200.00
Aug 17, 2026	Judah Frommer	Morgan Stanley	Maintains	Buy	$201.00 → $206.00 +5.00 (+2.5%)
Aug 15, 2026	Michael Okunewitch	Maxim	Maintains	Buy	$200.00
Aug 14, 2026	Michael Okunewitch	Maxim	Maintains	Buy	$200.00
Aug 14, 2026	Steven Seedhouse	Cantor Fitzgerald	Maintains	Buy	$266.00 → $270.00 +4.00 (+1.5%)
Aug 12, 2026	Steven Seedhouse	Cantor Fitzgerald	Maintains	Buy	$266.00 → $270.00 +4.00 (+1.5%)
Aug 12, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-

Yi Chen

HC Wainwright

BuyReiterates

$245.00

Oct 15

Graig Suvannavejh

Mizuho

BuyMaintains

$220.00 → $234.00

Sep 9

Zacks Equity Research

HoldInitiates Coverage

Sep 9

Yi Chen

HC Wainwright

BuyReiterates

$214.00 → $245.00

Sep 8

Whitney Ijem

Canaccord Genuity

BuyInitiates

$303.00

Sep 4

Tazeen Ahmad

BofA Securities

BuyMaintains

$200.00

Sep 3

Judah Frommer

Morgan Stanley

BuyMaintains

$201.00 → $206.00

Aug 17

Michael Okunewitch

Maxim

BuyMaintains

$200.00

Aug 15

Michael Okunewitch

Maxim

BuyMaintains

$200.00

Aug 14

Steven Seedhouse

Cantor Fitzgerald

BuyMaintains

$266.00 → $270.00

Aug 14

Steven Seedhouse

Cantor Fitzgerald

BuyMaintains

$266.00 → $270.00

Aug 12

Zacks Equity Research

HoldInitiates Coverage

Aug 12

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BLTE?

The analyst consensus rating for BLTE is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for BLTE?

The average 12-month price target for BLTE is $236.86, representing an upside of 65.2% from the Oct 26, 2026 close of $143.35.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.